本月全球药品研发进展取得成效的药物有51个,较上月减少了1个,其中进入注册阶段的药物数量较上月显著增加,进入注册前阶段和Ⅲ期临床研究阶段的药品数量均减少。进入注册阶段的有32个,较上月大幅增加了8个。其中12个为全球首次注册的新活性物质和新制剂,其余20个均为在新市场补充注册。本月全球首次注册12个药品,是上月的一倍。其中10个为新活性物质,2个为新制剂。10个新活性物质分 There were 51 pharmaceuticals that made progress in global pharmaceutical research and development this month, a decrease of 1 last month. The number of drugs entering the registration phase increased significantly from the previous month and the number of drugs entering the pre-registration phase and the phase III clinical research phase decreased . There were 32 entries in the registration phase, a sharp increase of 8 from the previous month. Twelve of these are the first new active substances and new preparations registered in the world and the remaining 20 are newly registered in the new markets. This month the world’s first registration of 12 drugs, double the previous month. Of these, 10 were new actives and 2 were new preparations. 10 new active substances points